A high-level overview of Blueprint Medicines Corporation (BPMC) stock. View (BPMC) real-time stock price, chart, news, analysis, analyst reviews and more.

Learn about June 2025’s top biotech deals, featuring major collaborations in small molecules, protein therapeutics, and ...

Roche has signed a global collaboration worth up to $1.7 billion with cancer drugs firm Blueprint Medicines based around pralsetinib, a drug that targets tumours with RET mutations.

Learn about the executive team and board of directors at Blueprint Medicines Corp (BPMC:XNAS) and review their bios and compensation over the latest fiscal years.

(STAT News) How a dinner in Paris revived talks for Sanofi’s $9.5 billion deal for Blueprint Medicines. For Blueprint Medicines, a monumental meal in the City of Bridges helped bring back to life ...

Since Blueprint Medicines’ inception over a decade ago, we have focused on advancing the understanding of the underlying cause of systemic mastocytosis (SM), and improving clinical care for this ...

AbbVie ABBV has been actively ramping up its deal-making efforts lately, thereby strengthening its pipeline. While immunology ...

Find the latest Blueprint Medicines Corporation (BPMC) stock quote, history, news and other vital information to help you with your stock trading and investing.

From new industry M&As to insights on how to recruit Gen Z talent, there’s plenty to discover in our latest pharma news round ...

A new study led by UC San Diego’s Scripps Institution of Oceanography may pave way for lab-based production of rare corals that fight cancer.